ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages 473-482

  Nakajima, Katsuyuki ^a   Nakajima, Yasuhiro ^a   Takeichi, Sanae ^a   Fujita, Masaki Q ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ApoB 48; Chylomicron (CM) remnants; Coronary atherosclerosis; Pokkuri death syndrome; Postprandial hyperlipidemia; Remnant like lipoprotein particles (RLP); RLP apoB 100; Sudden cardiac death (SCD); VLDL remnants

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ATHEROGENESIS; AUTOPSY; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART WEIGHT; HUMAN; HUMAN TISSUE; JAPAN; LIPOPROTEIN BLOOD LEVEL; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH; SUDDEN DEATH; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; AUTOPSY; CASE-CONTROL STUDIES; CHYLOMICRONS; DEATH, SUDDEN, CARDIAC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 34848923959     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.08.057     Document Type: Article

References (33)

1. Twickler T.B., Dallinga-Thie G.M., Cohn J.S., and Chapman M.J. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype. Circulation 109 (2004) 1918-1925
2. Nakajima K., Nakano T., and Tanaka A. The oxidative modification hypothesis of atherosclerosis: The comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin Chim Acta 367 (2006) 36-47
3. Sakata K., Miho N., Shirotani M., Yoshida H., and Takada A. Remnant-like particles cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery. Atherosclerosis 136 (1998) 225-231
4. Miwa K., Makita T., Ihsii K., Okuda N., and Taniguchi A. High remnant lipoprotein levels in patients with variant angina. Clin Cardiol 27 (2004) 338-425
5. Kasteline J.J., Jukema I.W., Zwinderman A.H., et al. Lipoprotein lipase activity is associated with severity of angina pectoris. Circulation 102 (2000) 1629-1633
6. Igarashi Y., Tamura Y., Suzuki K., et al. Coronary artery spasm is a major cause of sudden cardiac arrest in surviors without underlying heart disease. Coron Artery Dis 4 (1993) 177-185
7. Takeichi S., Nakajima Y., Osawa M., et al. The possible role of remnant-like particles as a risk factor for sudden cardiac death. Int J Legal Med 110 (1997) 213-219
8. Takeichi S., Yukawa N., Nakajima Y., et al. Association of plasma triglyceride-rich lipoprotein remnants with coronary artery atherosclerosis in cases of sudden cardiac death. Atherosclerosis 142 (1999) 309-315
9. Takeichi S., Nakajima Y., Yukawa N., et al. Association of plasma triglyceride-rich lipoprotein remnants with "Pokkuri disease". Legal Med 3 (2001) 84-94
10. Ohara N., Takeichi S., Naito Y., et al. Remnant-like particles from subjects who died of coronary artery disease suppress NO synthetase activity and attenuate endothelium-dependent vasorelaxation. Clin Chim Acta 338 (2003) 151-156
11. Takeichi S., Nakajima Y., Yukawa N., et al. Validity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary death. Clin Chim Acta 343 (2004) 93-10311
12. Oi K., Shimokawa H., Hiroki J., et al. Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic avtivity through upregulation of Rho-kinase. Arterioscler Thromb Vasc Biol 24 (2004) 918-92211
13. Nakajima K., Saito T., Tamura A., et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti A-1 immunoaffinity mixed gels. Clin Chim Acta 223 (1993) 53-71
14. Campos E., Nakajima K., Tanaka A., and Havel R.J. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res 33 (1992) 369-380
15. Schneeman B.O., Kotite L., Todd K.M., and Havel R.J. Relationships between the responses of triglyceride rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci USA 90 (1993) 2069-2073
16. Nakajima K., Okazaki M., and Tanaka A. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo-A1. J Clin Ligand Assay 19 (1996) 177-183
17. Marcoux C., Tremblay M., Nakajima K., Davignon J., and Cohn J.S. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipidemic patients. J Lipid Res 40 (1999) 636-647
18. Kinoshita M., Kojima M., Matsushima T., and Teramoto T. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta 351 (2005) 115-120
19. Sakai N., Uchida Y., Ohashi K., et al. Measurement of fasting serum.apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. J Lipid Res 44 (2003) 1256-1262
20. Usuki Y., and Mokuno H. Characterization of lipoproteins containing apolipoprotein B-100 in remnant-like partcles (RLP) and its association with coronary artery disease (CAD). Juntendoh-Igaku 46 (2000) 48-61
21. Imke C., Rodriguez B.L., Grove J.S., et al. Are remanat-like particles independent predictors of coronary heart disease incidence? The Honolulu heart study. Arterioscler Thromb Vasc Biol 25 (2005) 1718-1722
22. Ooi T.C., Cousins M., Ooi D.S., et al. Postprandial remnant- like lipoproteins in hypertriglyceridemia. J Clin Endocrinol Metab 86 (2001) 3134-3142
23. Cohn J.S., McNamara J.R., Cohn S.D., et al. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J. Lipid Res 29 (1988) 925-936
24. Karpe F., Steiner G., Olivecrona T., Carison L.A., and Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J. Clin. Invest. 91 (1993) 748-758
25. Iso H., Naito Y., Sato S., et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol 153 (2001) 490-499
26. Phillips N.R., Waters D., and Havel R. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88 (1993) 2762-2770
27. Okazaki M., Usui S., Tada N., Nakano T., and Nakajima K. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC. Clin Chim Acta 296 (2000) 135-149
28. Campos E., Kotite L., Blanche P., et al. Propertis of triglyceride-rich and cholesterol-rich lipoproteins in remnant-like particle fraction of human blood plasma. 43 (2002) 365-374
29. Chait A., Mancini M., Feburary A.W., et al. Clinical and metabolic study of alcoholic hyperlipidemia. Lancet 8 (1972) 62-64
30. Pownall. Dietary ethanol is associated with reduced lipolysis of intestinally drived lipoproteins. J Lipid Res 1994;35:2105-13.
31. Castelli W.P., Gordon T., Hjortland M.G., et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet 2 (1977) 153-155
32. Taskinen M.R., and Nikkila E.A. Nocturnal hypertriglyceridemia and hyperinsulinemia following moderate evening intake of alcohol. Acta Med Scand 202 (1977) 173-177
33. Schneider J., Liesenfeld A., Mordasini R., et al. Lipoprotein fractions, lipoprotein lipase and hepatic triglyceride lipase during short-term and long term uptake of ethanol in healthy subjects. Atherosclerosis 57 (1985) 281-291